Back to mobile site

Brean Murray Carret & Co. Says Shares of InterMune (ITMN) Undervalued Despite Pressure from Esbriet Sales

April 27, 2012 10:52 AM EDT
Get Alerts ITMN Hot Sheet
Price: $73.89 --0%

Rating Summary:
    8 Buy, 9 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Brean Murray Carret & Co. maintains a 'Buy' on InterMune Inc. (NASDAQ: ITMN) price target of $33.00.

Analyst, Brian Skorney, said, "Topline Esbriet sale came in short of dampened expectations, with $4.9 million in net sales. We expect the top-line miss to further fuel negative sentiment plaguing the stock in recent weeks. Although an actual breakout of new patient starts put the quarter in a more positive light, we see the decrease in new starts in Germany relative to last qtr as a disappointment and are adjusting our growth trajectory accordingly...We continue to maintain our belief that ITMN shares remain substantially undervalued on a risk-adjusted cash flow basis."

Brean analyst cuts FY12 EPS loss from (2.47) to (2.86) and FY13 from (1.13) to (1.45)

For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.

Shares of InterMune Inc. closed at $12.45 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Brean Murray Carret & Co.